Demonstration of resolution of amlodipine induced pedal edema by cilnidipine

Kiran Shetty, Ranjan Shetty, Pragna Rao, Deepak, Sravan Reddy, Vidya Nayak

Research output: Contribution to journalArticle

Abstract

The aim of the study is to demonstrate the resolution of Amlodipine induced pedal edema by substitution of Cilnidipine with an adequate hypertension control. This was a prospective, Interventional study. Conducted at the tertiary care center in south India. A total number of 66 (n = 66) patients with essential hypertension with the amlodipine-induced edema of both genders, attending the outpatient department of medicine and cardiology, were included in the study. Amlodipine induced pedal edema was confirmed by various tests. After the Initial screening, amlodipine therapy was substituted to Cilnidipine with an efficacy equivalent dose. Clinical and biochemical parameters measured at the onset of the study and reassessed after 4 weeks of Cilnidipine therapy. At the end of the study, amlodipine-induced pedal edema was completely resolved in all the patients. There was a significant decrease in vanillyl mandelic acid (VMA) and (P <0.001), which is end metabolite of catecholamine. There was a substantial reduction in bilateral ankle circumference, Body weight and BMI (P <0.001). There was a significant decrease in blood pressure and pulse rate (P <0.001). Cilnidipine therapy leads to a complete resolution of amlodipine-induced edema, along with a better hypertension control. Cilnidipine is decreasing the release of catecholamine by inhibiting N-type of calcium channels at the neuronal terminal. Cilnidipine is a suitable alternative antihypertensive medication for patients with the amlodipine-induced edema.

Original languageEnglish
Article number42
Pages (from-to)229-233
Number of pages5
JournalInternational Journal of Pharmaceutical Sciences Review and Research
Volume41
Issue number1
Publication statusPublished - 01-11-2016

Fingerprint

Amlodipine
Foot
Edema
Catecholamines
N-Type Calcium Channels
Hypertension
cilnidipine
Cardiology
Tertiary Care Centers
Ankle
Antihypertensive Agents
India
Outpatients
Therapeutics
Heart Rate
Body Weight
Medicine
Prospective Studies
Blood Pressure

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Shetty, Kiran ; Shetty, Ranjan ; Rao, Pragna ; Deepak ; Reddy, Sravan ; Nayak, Vidya. / Demonstration of resolution of amlodipine induced pedal edema by cilnidipine. In: International Journal of Pharmaceutical Sciences Review and Research. 2016 ; Vol. 41, No. 1. pp. 229-233.
@article{bc5fbf3d73fe4acaacb7fe45fae5df58,
title = "Demonstration of resolution of amlodipine induced pedal edema by cilnidipine",
abstract = "The aim of the study is to demonstrate the resolution of Amlodipine induced pedal edema by substitution of Cilnidipine with an adequate hypertension control. This was a prospective, Interventional study. Conducted at the tertiary care center in south India. A total number of 66 (n = 66) patients with essential hypertension with the amlodipine-induced edema of both genders, attending the outpatient department of medicine and cardiology, were included in the study. Amlodipine induced pedal edema was confirmed by various tests. After the Initial screening, amlodipine therapy was substituted to Cilnidipine with an efficacy equivalent dose. Clinical and biochemical parameters measured at the onset of the study and reassessed after 4 weeks of Cilnidipine therapy. At the end of the study, amlodipine-induced pedal edema was completely resolved in all the patients. There was a significant decrease in vanillyl mandelic acid (VMA) and (P <0.001), which is end metabolite of catecholamine. There was a substantial reduction in bilateral ankle circumference, Body weight and BMI (P <0.001). There was a significant decrease in blood pressure and pulse rate (P <0.001). Cilnidipine therapy leads to a complete resolution of amlodipine-induced edema, along with a better hypertension control. Cilnidipine is decreasing the release of catecholamine by inhibiting N-type of calcium channels at the neuronal terminal. Cilnidipine is a suitable alternative antihypertensive medication for patients with the amlodipine-induced edema.",
author = "Kiran Shetty and Ranjan Shetty and Pragna Rao and Deepak and Sravan Reddy and Vidya Nayak",
year = "2016",
month = "11",
day = "1",
language = "English",
volume = "41",
pages = "229--233",
journal = "International Journal of Pharmaceutical Sciences Review and Research",
issn = "0976-044X",
publisher = "Global Research Online",
number = "1",

}

Demonstration of resolution of amlodipine induced pedal edema by cilnidipine. / Shetty, Kiran; Shetty, Ranjan; Rao, Pragna; Deepak; Reddy, Sravan; Nayak, Vidya.

In: International Journal of Pharmaceutical Sciences Review and Research, Vol. 41, No. 1, 42, 01.11.2016, p. 229-233.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Demonstration of resolution of amlodipine induced pedal edema by cilnidipine

AU - Shetty, Kiran

AU - Shetty, Ranjan

AU - Rao, Pragna

AU - Deepak,

AU - Reddy, Sravan

AU - Nayak, Vidya

PY - 2016/11/1

Y1 - 2016/11/1

N2 - The aim of the study is to demonstrate the resolution of Amlodipine induced pedal edema by substitution of Cilnidipine with an adequate hypertension control. This was a prospective, Interventional study. Conducted at the tertiary care center in south India. A total number of 66 (n = 66) patients with essential hypertension with the amlodipine-induced edema of both genders, attending the outpatient department of medicine and cardiology, were included in the study. Amlodipine induced pedal edema was confirmed by various tests. After the Initial screening, amlodipine therapy was substituted to Cilnidipine with an efficacy equivalent dose. Clinical and biochemical parameters measured at the onset of the study and reassessed after 4 weeks of Cilnidipine therapy. At the end of the study, amlodipine-induced pedal edema was completely resolved in all the patients. There was a significant decrease in vanillyl mandelic acid (VMA) and (P <0.001), which is end metabolite of catecholamine. There was a substantial reduction in bilateral ankle circumference, Body weight and BMI (P <0.001). There was a significant decrease in blood pressure and pulse rate (P <0.001). Cilnidipine therapy leads to a complete resolution of amlodipine-induced edema, along with a better hypertension control. Cilnidipine is decreasing the release of catecholamine by inhibiting N-type of calcium channels at the neuronal terminal. Cilnidipine is a suitable alternative antihypertensive medication for patients with the amlodipine-induced edema.

AB - The aim of the study is to demonstrate the resolution of Amlodipine induced pedal edema by substitution of Cilnidipine with an adequate hypertension control. This was a prospective, Interventional study. Conducted at the tertiary care center in south India. A total number of 66 (n = 66) patients with essential hypertension with the amlodipine-induced edema of both genders, attending the outpatient department of medicine and cardiology, were included in the study. Amlodipine induced pedal edema was confirmed by various tests. After the Initial screening, amlodipine therapy was substituted to Cilnidipine with an efficacy equivalent dose. Clinical and biochemical parameters measured at the onset of the study and reassessed after 4 weeks of Cilnidipine therapy. At the end of the study, amlodipine-induced pedal edema was completely resolved in all the patients. There was a significant decrease in vanillyl mandelic acid (VMA) and (P <0.001), which is end metabolite of catecholamine. There was a substantial reduction in bilateral ankle circumference, Body weight and BMI (P <0.001). There was a significant decrease in blood pressure and pulse rate (P <0.001). Cilnidipine therapy leads to a complete resolution of amlodipine-induced edema, along with a better hypertension control. Cilnidipine is decreasing the release of catecholamine by inhibiting N-type of calcium channels at the neuronal terminal. Cilnidipine is a suitable alternative antihypertensive medication for patients with the amlodipine-induced edema.

UR - http://www.scopus.com/inward/record.url?scp=85002323086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002323086&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 229

EP - 233

JO - International Journal of Pharmaceutical Sciences Review and Research

JF - International Journal of Pharmaceutical Sciences Review and Research

SN - 0976-044X

IS - 1

M1 - 42

ER -